AR043539A1 - Vacunas bovinas potenciadas - Google Patents

Vacunas bovinas potenciadas

Info

Publication number
AR043539A1
AR043539A1 ARP040100772A ARP040100772A AR043539A1 AR 043539 A1 AR043539 A1 AR 043539A1 AR P040100772 A ARP040100772 A AR P040100772A AR P040100772 A ARP040100772 A AR P040100772A AR 043539 A1 AR043539 A1 AR 043539A1
Authority
AR
Argentina
Prior art keywords
coli
animal
composition
potentiated
vaccine
Prior art date
Application number
ARP040100772A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR043539A1 publication Critical patent/AR043539A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Composición para una vacuna que es inocua y eficaz contra la diseminación de E. coli O157:H7. Reivindicación 1: Una composición para una vacuna, que comprende: un componente inmunogénicamente activo seleccionado del grupo que consiste en E. coli O157:H7 inactivado o muerto entero o en sub-unidades, o mezclas de los mismos; un coadyuvante de aceite metabolizable; y opcionalmente un portador farmacéuticamente aceptable. Reivindicación 13: Un método para educir la diseminación de E. coli O157:H7 en un animal que comprende el tratamiento del animal con una composición de acuerdo con la reivindicación 1. Reivindicación 14: Un método de acuerdo con la reivindicación 13 que comprende además el tratamiento del animal con un Lactobacillus acidophillis o un suplemento alimenticio medicado con neomicina.
ARP040100772A 2003-03-12 2004-03-10 Vacunas bovinas potenciadas AR043539A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45418203P 2003-03-12 2003-03-12

Publications (1)

Publication Number Publication Date
AR043539A1 true AR043539A1 (es) 2005-08-03

Family

ID=32990880

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100772A AR043539A1 (es) 2003-03-12 2004-03-10 Vacunas bovinas potenciadas

Country Status (12)

Country Link
US (1) US20040180060A1 (es)
EP (1) EP1601375A2 (es)
JP (1) JP2006519880A (es)
AR (1) AR043539A1 (es)
AU (2) AU2004220543A1 (es)
BR (1) BRPI0408249A (es)
CA (1) CA2517498A1 (es)
CO (1) CO5660272A2 (es)
MX (1) MXPA05009447A (es)
NZ (1) NZ542253A (es)
TW (1) TWI350174B (es)
WO (1) WO2004080400A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5100122B2 (ja) 2003-10-31 2012-12-19 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア 細菌の病原因子とそれらの使用
JP5869221B2 (ja) * 2007-11-06 2016-02-24 ゾエティス・ダブリュー・エルエルシー アジュバント添加マイコプラズマ・ハイオニューモニエ非病原性生ワクチン
MX2012004133A (es) * 2009-10-07 2012-05-08 Wyeth Llc Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas.
BR112013027845A2 (pt) * 2011-05-18 2017-01-03 Ajinomoto Kk Imunoestimulante, ração, método para produzir um imunoestimulante, e, método para imunoestimulação
JP6586083B2 (ja) * 2013-09-19 2019-10-02 ゾエティス・サービシーズ・エルエルシー 油性アジュバント

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0827028A (ja) * 1994-07-21 1996-01-30 Nippon Seibutsu Kagaku Kenkyusho 油性アジュバント及びアルミニウムゲルアジュバントからなる動物用ワクチン製剤
US5730989A (en) * 1995-02-16 1998-03-24 Novavax, Inc. Oral vaccine against gram negative bacterial infection
US5976580A (en) * 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
JP4282804B2 (ja) * 1998-12-24 2009-06-24 新日本石油株式会社 アジュバント組成物
WO2000051634A1 (fr) * 1999-03-03 2000-09-08 The Kitasato Institute Preparations de vaccins contenant des acides gras comme composants
GB9923176D0 (en) * 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
JP2001131087A (ja) * 1999-11-05 2001-05-15 Chemo Sero Therapeut Res Inst オイルアジュバントワクチン
AU777145B2 (en) * 1999-11-29 2004-10-07 Intervet International B.V. Antigenic protein LPPQ of Mycoplasma mycoidessubsp.(mycoides)SC., its preparation and use
US6162441A (en) * 1999-12-15 2000-12-19 Republic Of Korea (Management: Rural Development Administration) Method for the production of anti-escherichia. coli O157 : H7 antibody
AUPQ761200A0 (en) * 2000-05-19 2000-06-15 Hunter Immunology Limited Compositions and methods for treatment of mucosal infections
US7560484B2 (en) * 2000-08-31 2009-07-14 The Kitasato Institute Vaccine preparation containing fatty acid as a constituent
NZ527322A (en) * 2001-01-04 2005-07-29 Univ Saskatchewan EHEC cell culture supernatant vaccine
EP1372708B1 (en) * 2001-02-13 2008-06-18 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE ARMY Vaccine for transcutaneous immunization against travellers' diarrhoea
EP1314359A1 (en) * 2001-11-21 2003-05-28 N.V. Seghers Nutrition Sciences Growth promoter composition for animals

Also Published As

Publication number Publication date
WO2004080400A2 (en) 2004-09-23
AU2010202344A1 (en) 2010-07-01
NZ542253A (en) 2008-07-31
MXPA05009447A (es) 2005-11-23
AU2004220543A1 (en) 2004-09-23
US20040180060A1 (en) 2004-09-16
BRPI0408249A (pt) 2006-03-01
TWI350174B (en) 2011-10-11
CA2517498A1 (en) 2004-09-23
TW200423956A (en) 2004-11-16
CO5660272A2 (es) 2006-07-31
JP2006519880A (ja) 2006-08-31
WO2004080400A3 (en) 2005-03-03
EP1601375A2 (en) 2005-12-07

Similar Documents

Publication Publication Date Title
Sahoo et al. Immunomodulation by dietary vitamin C in healthy and aflatoxin B1-induced immunocompromised rohu (Labeo rohita)
Gudding et al. A history of fish vaccination: science-based disease prevention in aquaculture
PE20190451A1 (es) Composiciones que comprenden cepas bacterianas
AR052399A1 (es) Metodo para tratar o prevenir una infeccion causada por microbios, composicion para el mismo y metodos para desinfectar dispositivos y para prevenir las infecciones que se originan en dispositivos medicos
AR083395A1 (es) Derivado peptidico nmu (neuromedina u) con elevado efecto anorectico
GT200300180A (es) Vacunas para enfermedades reproductoras del ganado
NO20056223L (no) Preparat til behandling av infeksjon hos kveg og svin
AR054844A1 (es) Vacuna contra lawsonia y metodos de uso de la misma
AR044007A1 (es) Metodos para el tratamiento de la enfermedad de parkinson
AR064009A1 (es) Metodo de inmunizacion contra los 4 serotipos del dengue
GT200200138A (es) Vacunacion en dosis unica con mycoplasma hyopneumoniae
TW200602068A (en) Antidiarrheal agent for livestock and poultry
BR0313474A (pt) dispositivo de distribuição transdérmica de vacina tendo microprotuberáncias revestidas
CO6190623A2 (es) Vacuna salmonella
AR038852A1 (es) Una composicion parasiticida
AR008799A1 (es) Composicion de vacuna para prevenir o tratar el paludismo; uso de dicha composicion para elaborar medicamentos y metodo para dicha profilaxis y dichotratamiento
CL2011000877A1 (es) Composicion inmunogena para el tratamiento y/o profilaxis de ganado contra infecciones microbiologicas porque comprende antigeno de mycoplasma bovis; metodo de coadministracion de dos o mas antigenos a un ganado bovino.
AR112166A1 (es) Composiciones terapéuticas y métodos para el tratamiento de hepatitis b
AR043539A1 (es) Vacunas bovinas potenciadas
AR081973A1 (es) Composiciones y metodos para incrementar la reduccion de microorganismos formadores de esporas
Yamin et al. The protective effect of humic-rich substances from monogenean parasites infecting the guppy (Poecilia reticulata)
Thinh et al. Combined immersion and oral vaccination of Vietnamese catfish (Pangasianodon hypophthalmus) confers protection against mortality caused by Edwardsiella ictaluri
AR039982A1 (es) Composicion vacunal contra las alergias, metodo para su obtencion y empleo en el tratamiento de las mismas
AR036355A1 (es) Modelo de exposicion a mycoplasma bovis, para evaluar la eficacia de potenciales vacunas
AR048671A1 (es) Procedimiento de vacunacion contra la infeccion testicular por bvdv

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FB Suspension of granting procedure
FC Refusal
FB Suspension of granting procedure